Oculis Pharma (private company)
See something wrong or missing? Let us know
Offices:Reykjavik
Industry:Pharma
Business model:B2B
Oculis is a clinical-stage, privately held, pharmaceutical development company focusing on ophthalmic drugs and novel drug delivery to the eye.
Oculis has developed a drug delivery platform consisting of a novel technique to facilitate drug absorption to both anterior and posterior parts of the eye. The advantage is a drug delivery system where diseases of the posterior part of the eye can be treated with a simple topical application, i.e. an eye drop.
Investors:
we tracked 11 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 193.02M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Oculis Pharma
Name | Criteria | |
---|---|---|
![]() |
1000Farmacie
43%
|
|
![]() |
Beckley Psytech
43%
|
|
![]() |
Bigfinite
43%
|
|
![]() |
Desentum
43%
|
|
![]() |
Forendo Pharma
43%
|
|
![]() |
NMD Pharma
43%
|
|
![]() |
Ona Therapeutics
43%
|
|
![]() |
OxThera
43%
|
|
![]() |
Qualifyze
43%
|
|
![]() |
Sanifit Therapeutics
43%
|
|